Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+98.4%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
+98.4%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
30.8x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 448.21% |
| 2023 | -98.35% |
| 2022 | -31.32% |
| 2021 | -3.29% |
| 2020 | -11.02% |
| 2019 | 14.56% |
| 2018 | 158.68% |
| 2017 | 310.17% |
| 2016 | 84.38% |
| 2015 | -28.29% |